Aβ42 oligomer-specific antibody ALZ-201 reduces the neurotoxicity of Alzheimer’s disease brain extracts

BACKGROUND: In Alzheimer’s disease (AD), amyloid-β 1–42 (Aβ42) neurotoxicity stems mostly from its soluble oligomeric aggregates. Studies of such aggregates have been hampered by the lack of oligomer-specific research tools and their intrinsic instability and heterogeneity. Here, we developed a mono...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandberg, Anders, Berenjeno-Correa, Ernesto, Rodriguez, Rosa Crespo, Axenhus, Michael, Weiss, Sophia Schedin, Batenburg, Kevin, Hoozemans, Jeroen J. M., Tjernberg, Lars O., Scheper, Wiep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798723/
https://www.ncbi.nlm.nih.gov/pubmed/36578089
http://dx.doi.org/10.1186/s13195-022-01141-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798723/
https://www.ncbi.nlm.nih.gov/pubmed/36578089
http://dx.doi.org/10.1186/s13195-022-01141-1

Ejemplares similares